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Abstract
Hepcidin is the master regulator of iron homeostasis. In the liver, iron-dependent hepcidin activation is regulated through Bmp6 and
its membrane receptor hemojuvelin (Hjv) whereas, in response to iron deficiency, hepcidin repression seems to be controlled by a
pathway involving the serine protease matriptase-2 (encoded by ). To determine the relationship between Bmp6 andTmprss6 
matriptase-2 pathways, mice (characterized by increased hepcidin levels and anemia) and mice (exhibitingTmprss6 /  − − Bmp6 /  − −
severe iron overload due to hepcidin deficiency) were intercrossed. We showed that loss of Bmp6 decreased hepcidin levels, increased
hepatic iron and, importantly, corrected hematological abnormalities in mice. This suggests that elevated hepcidin levelsTmprss6 /  − −
in patients with familial iron-refractory iron deficiency anemia are due to excess signaling through the Bmp6/Hjv pathway.
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Introduction
Body iron supply is provided both by iron recycling from senescent erythrocytes within the reticuloendothelial system and dietary iron
absorption by duodenal enterocytes . The liver-iron regulatory hormone, hepcidin, controls these two iron-delivery pathways via its[1 ]
targeted degradation of the cell surface iron exporter, ferroportin. As a consequence, iron availability in the circulation is decreased,
leading to hypoferraemia , . Neither the lack of hepcidin nor its excess can be compensated for by the body, the results of which[2 3 ]
ultimately manifest in either iron overload or iron deficiency anemia, respectively.
Hepcidin gene expression is tightly regulated by body iron status and is dependent upon bone morphogenetic protein 6 (Bmp6) and
hemojuvelin (Hjv). Binding of the iron-regulated Bmp6 ligand  to its receptors activates a signaling cascade leading to hepcidin[4 ]
transcription via phosphorylation of son of mother against decapentaplegic (Smad) 1/5/8 effectors . Hjv, a GPI-linked membrane protein[5 ]
synthesized by the hepatocytes, is a Bmp6 coreceptor . The critical role of the Bmp6/Hjv/Smad pathway in iron homeostasis is[5 ]
supported by the loss of hepcidin expression and massive parenchymal iron overload observed in and mice as well as inBmp6 /  − − Hjv /  − −
mice with targeted liver deletion of Smad4 .[6 –9 ]
Recently, the serine protease matriptase-2 (also known as TMPRSS6) has been connected to this iron-pathway  due to its[10 –12 ]
proteolysis of Hjv . Matriptase-2 is a type II serine protease that is predominately expressed in the liver (for review ). Matriptase-2[13 ] [14 ]
deficient mice ,  have very high levels of hepcidin, which lead to the inhibition of dietary iron absorption and cause a severe iron[10 12 ]
deficiency anemia phenotype. Matriptase-2 was thus characterized as a negative regulator of hepcidin gene expression. Accordingly, Du et
al. demonstrated that overexpression of normal matriptase-2 protein in hepatoma cells suppresses the activation of hepcidin expression[10 ]
. The anemic phenotype of matriptase-2 deficient mice is mirrored in patients with matriptase-2 mutations who present with iron-refractory
iron deficiency anemia (IRIDA) . Indeed, IRIDA patients show inappropriately high hepcidin levels , , , which explain lack of[11 ] [11 14 15 ]
dietary iron absorption and partial response to parenteral iron treatment .[16 ]
The goal of this study was to characterize the relationship between matriptase-2 and the iron-regulated ligand of Hjv, Bmp6, byin vivo 
analyzing the role of Bmp6 in the setting of anemia in mice deficient for matriptase-2. Towards this purpose, we intercrossed matriptase-2
and Bmp6-deficient mice and compared the iron status of the double mutant mice with that of wild-type controls or single mutant mice.
Material and methods
Matriptase-2 and Bmp6 deficiency in mice
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mice on a mixed 129/Ola x C57BL/6 background  were mated to mice on an outbred CD1 backgroundTmprss6tm1Otin [12 ] Bmp6tm1Rob [
. F1 mice, heterozygous for both the (hereafter referred to as ) and the alleles (referred to as 6 ] Tmprss6tm1Otin Tmprss6 / +  − Bmp6tm1Rob 
) were then intercrossed and the F2 progeny genotyped as previously described , . As expected, the nine possible genotypicBmp6  + /  − [6 12 ]
combinations were observed among the F2 mice.
Mice were cared for in accordance with the European convention for the protection of laboratory animals . Animals were given free« »
access to tap water and standard laboratory mouse chow diet (AO3, iron content 280 mg/kg, UAR, France). Mice used in this study were 8
to 13-week-old females and had a mixed 129/Ola  C57BL/6  CD1 background. Hematological parameters as well as plasma and liver× ×
iron were obtained as previously described .[17 ]
RNA extraction and real-time quantification of the hepcidin and  actin transcripts were performed as reported in . Standardizedβ [18 ]
genetic nomenclature for mouse hepcidin is Hamp and Atcb for  actin.β
Student tests were used to compare quantitative traits between mouse groups. values less than .05 were considered as statisticallyt P 
significant.
Results and discussion
To investigate the role of Bmp6 in the pathogenesis of iron-refractory iron deficiency anemia, we intercrossed matriptase-2 and
Bmp6-deficient mice and analyzed iron metabolism in their F2 progeny.
As recently published , , liver hepcidin expression was repressed in mice compared with controls ( ),[6 7 ] Bmp6 /  − − Bmp6 /  + + Fig. 1A 
leading to increased liver and plasma iron levels ( ). , a marker of activation of the Bmp/Smad signaling pathway, had anFig. 1B & C Id1 
expression pattern similar to that of hepcidin in these mice ( ). However, their expression of was notBmp6 /  − − Fig. 1D Tmprss6 
significantly different from the wild-type controls (data not shown). Furthermore, as shown in , hematological parameters of Table 1 Bmp6
mice were similar to those of controls./  − − Bmp6 /  + +
Conversely, hepcidin and gene expressions were significantly up-regulated in mice ( ), and as expectedId1 Tmprss6 /  − − Fig. 1A & D [
, these mice had reduced hepatic and plasma iron indices, compared with controls ( ). In addition, 12 ] Tmprss6 /  + + Fig. 1B & C Tmprss6 /  − −
mice were anemic and presented with significantly decreased Hb levels, as well as RBC, Hct and MCV ( ). In addition, asTable 1 
previously reported , they exhibited lower gene expression than wild-type controls (data not shown).[19 ] Bmp6 
Interestingly, in double mutant mice, hepcidin expression was repressed to the same extent as in miceBmp6 /  − −Tmprss6 /  − − Bmp6 /  − −
( ). A similar pattern of expression was observed for , although the comparison did not reach statistical significance, due to aFig. 1A Id1 
slightly higher variability of gene expression levels between mice for than for hepcidin ( ). In addition, phosphorylation ofId1 Fig. 1D 
Smad1/5/8 appeared similarly decreased in mice and in mice, compared with wild-typeBmp6 /  − − Tmprss6 /  + + Bmp6 /  − − Tmprss6 /  − −
controls (data not shown), which is concordant with the similar reduction we observed in their levels of hepcidin expression. However,
although liver and plasmatic iron levels were higher in mice than in mice, these levels remainedBmp6 /  − − Tmprss6 /  − − Bmp6 /  + +
significantly lower than in mice ( ). Lastly, and most importantly, iron deficiency anemia observed in the Bmp6 /  − − Fig. 1B & C Tmprss6 /−
mice was completely rescued by deficiency. As shown in , Hb, Hct and MCV values observed in  − Bmp6 Table 1 Bmp6 /  − − Tmprss6 /  − −
mice were comparable to control values. Furthermore, heterozygous loss of in mice was able to partially correctBmp6 Tmprss6 /  − −
systemic iron homeostasis by decreasing hepcidin gene expression and increasing plasma and liver iron ( ).Fig. 1 
Although hematological parameters were found to be normal in mice deficient for both Hjv and matriptase-2 , , supporting the[19 20 ]
role of matriptase-2 as a regulator of Hjv expression at the hepatocyte membrane, the role of Bmp6 in this process was not clearly defined.
The data obtained in this study indicate that hepcidin overexpression which results from matriptase-2 inactivation requires the presence of
Bmp6. Indeed, neither the activation of the Hjv/Smad signaling pathway nor the establishment of the anemic phenotype were observed in
double knockout mice.
However, in contrast to mice ,  which had a phenotype very similar to mice, we found that loss ofHjv /  − − Tmprss6 /  − − [19 20 ] Hjv /  − −
matriptase-2 in mice attenuates the effects of Bmp6 deficiency on hepatic and plasma iron accumulation. It could beBmp6 /  − − Tmprss6 /  − −
speculated that, due to the lack of matriptase-2, Hjv is stabilized at the hepatocyte plasma membrane and can serve as a coreceptor for
ligands other than Bmp6. However, neither hepcidin nor gene expression were found up-regulated in the double mutant female miceId1 
compared with mice. Alternatively, matriptase-2 could, in absence of Bmp6, regulate other iron-related proteins or initiate aBmp6 /  − −
signaling pathway involved in maintaining hepatic iron balance and/or systemic iron regulation, independently of hepcidin.
Matriptase-2 and Bmp6 deficiency in mice
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In conclusion, the present data further support that Bmp6 is the physiological ligand of Hjv and demonstrate that the regulation of Hjv
membrane expression by matriptase-2 serves to tightly control the signaling pathway induced by Bmp6.
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Figure 1
Phenotypic analysis of female mice according to their genotypesBmp6/Tmprss6 
The phenotypes analyzed include hepcidin mRNA expression relative to -actin (A), non-heme iron concentration of liver (B), plasmatic ironβ
(C) and Id1 mRNA expression relative to -actin (D). Data are presented as mean  SD. β ± a, p<0.05 when compared with Bmp6 Tmprss6/  + + /  + +
controls. b, p<0.05 when compared with mice. Bmp6  − /  −Tmprss6 /  + + c, p<0.05 when compared with mice.Bmp6 Tmprss6 /  + + /  − −
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Table 1
Hematological parameters of female mice according to their genotypes.Bmp6/Tmprss6 
Genotype RBC (10 /L)12 Hb (g/dL) Hct ( )% MCV (fL)
Bmp6 /+ +
Tmprss6 /+ +
9,77  0,35± c 16,22  0,63± c 48,12  2,36± c 49,28  1,86± c
Bmp6 /+ −
Tmprss6 /+ +
9,59  0,49± c 16,01  0,62± c 47,96  2,46± c 50,04  1,62± c
Bmp6 /− −
Tmprss6 /+ +
9,52  0,48± c 16,40  0,66± c 48,61  2,01± c 51,13  2,12± c
Bmp6 /+ +
Tmprss6 /+ −
9,54  0,37± c 15,60  0,45± a b c 46,27  1,44± b c 48,52  1,86± b c
Bmp6 /+ −
Tmprss6 /+ −
9,53  0,35± c 16,08  0,59± c 47,67  2,69± c 50,10  2,26± c
Bmp6 /− −
Tmprss6 /+ −
9,45  0,45± c 16,51  0,72± c 48,98  2,57± c 51,82  1,62± a c
Bmp6 /+ +
Tmprss6 /− −
6,99  1,1± a b 11,97  1,44± a b 32,06  4,86± a b 45,94  1,02± a b
Bmp6 /+ −
Tmprss6 /− −
8,45  0,63± a b c 13,48  0,85± a b c 38,40  2,54± a b c 45,47  0,63± a b
Bmp6 /− −
Tmprss6 /− −
9,28  0,35± a c 15,92  1,13± c 46,88  4,08± c 50,42  2,61± c
RBC indicates red cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume. Data are presented as mean  SD.±
a 
,p<0.05 when compared with controls.Bmp6 Tmprss6/  + + /  + +
b p<0.05 when compared with mice.Bmp6 /  − −Tmprss6 /  + +
c p<0.05 when compared with mice.Bmp6 Tmprss6 /  + + /  − −
